Drug maker Ipca Laboratories today reported a fall of 65 per cent in its net profit for the fourth quarter ended March 31 to Rs 7.90 crore.
The company had a net profit of Rs 22.64 crore during the January-March quarter a year earlier, Ipca Lab said in a filing to the Bombay Stock Exchange.
However, the pharmaceutical company reported a rise in its total income during the fourth quarter to Rs 317.5 crore as against Rs 249.9 crore of the corresponding period a year ago.
The company declared a final dividend of Rs 4 per share for the financial year ended March 31, 2009.
For the financial year ended March 31, the company posted a net profit of Rs 91.22 crore, down 35 per cent as against Rs 141.12 crore of FY08.
Shares of Ipca Lab slipped over 4 per cent to hit its lower trading limit of Rs 486.70 on the BSE.
